Fig. 2From: Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancerDistribution of pre-treatment sample image metrics by tumour molecular subtype. Horizontal grey lines represent median values. Results of the Kruskal-Wallis test are depicted within graphs; red text denotes p values <0.05. ER oestrogen receptor, HER2 human epidermal growth factor receptor 2Back to article page